Showing 341 - 360 results of 2,406 for search '"SARS"', query time: 0.10s Refine Results
  1. 341

    Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis by Rekha Joshi, Harsh Gaikwad, Bhavana Soge, Abdulrahman Alshammari, Norah A. Albekairi, Atul Kabra, Usha Yashwante, Baban Kolte, Pradip Lokhande, Rohan J Meshram

    Published 2025-01-01
    “…The detailed structural inspection of MD simulation trajectories sheds light on the structural and functional dynamics involved in the SARS-CoV-2 Mac-1. The data presented here is expected to guide the design and development of better anti-SARS-CoV-2 therapies.…”
    Get full text
    Article
  2. 342
  3. 343

    Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination by Francesca Dapporto, Serena Marchi, Margherita Leonardi, Pietro Piu, Piero Lovreglio, Nicola Decaro, Nicola Buonvino, Angela Stufano, Eleonora Lorusso, Emilio Bombardieri, Antonella Ruello, Simonetta Viviani, Eleonora Molesti, Claudia Maria Trombetta, Alessandro Manenti, Emanuele Montomoli

    Published 2022-01-01
    “…Background. The recently emerged SARS-CoV-2 Omicron variant exhibits several mutations on the spike protein, enabling it to escape the immunity elicited by natural infection or vaccines. …”
    Get full text
    Article
  4. 344

    Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa by C. Bekker, I. Dewandel, A. Redfern, C. McKenzie, J. Lishman, L. M. Verhagen, M. Claassen, S. Wilson, R. Dunbar, C. Bosch, G. van Zyl, W. Preiser, P. Goussard, H. Rabie, M. M. van der Zalm

    Published 2024-01-01
    “…We describe the clinical presentation of SARS-CoV-2 infection in children during the Omicron wave, in Cape Town, South Africa. …”
    Get full text
    Article
  5. 345

    Environmental surveillance of SARS-CoV-2 for outbreak detection in hospital: A single centre prospective study by Hania Siddiqui, Alexandra M.A. Hicks, Aaron Hinz, Prachi Ray, Jennie Johnstone, Derek R. MacFadden, Jason A. Moggridge, Michael Fralick

    Published 2025-02-01
    “…Swabs were assayed for SARS-CoV-2 by quantitative reverse-transcriptase polymerase chain reaction (RT-qPCR). …”
    Get full text
    Article
  6. 346
  7. 347
  8. 348

    A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2 by Ayrton Bangolo, Jeffin Cherian, Mohamed Ahmed, Ali Atoot, Bhavna Gupta, Adam Atoot

    Published 2022-01-01
    “…The Johnson and Johnson (J&J) vaccine developed against the novel SARS-CoV-2 has been linked to more specific cases of thrombosis, associated with low platelet levels similar to that seen in heparin-induced thrombocytopenia. …”
    Get full text
    Article
  9. 349
  10. 350
  11. 351

    Recognition and cleavage of human tRNA methyltransferase TRMT1 by the SARS-CoV-2 main protease by Angel D'Oliviera, Xuhang Dai, Saba Mottaghinia, Sophie Olson, Evan P Geissler, Lucie Etienne, Yingkai Zhang, Jeffrey S Mugridge

    Published 2025-01-01
    “…The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. …”
    Get full text
    Article
  12. 352
  13. 353
  14. 354

    A Fractional-Order Investigation of Vaccinated SARS-CoV-2 Epidemic Model with Caputo Fractional Derivative by Badr Saad T. Alkahtani

    Published 2022-01-01
    “…In this paper, we consider a fractional-order mathematical system comprising four different compartments for the recent pandemic of SARS-CoV-2 with regard to global and singular kernels of Caputo fractional operator. …”
    Get full text
    Article
  15. 355
  16. 356
  17. 357

    Clinical Accuracy of Instrument-Read SARS-CoV-2 Antigen Rapid Diagnostic Tests (Ag-IRRDTs) by Ali Umit Keskin, Pinar Ciragil, Aynur Eren Topkaya

    Published 2022-01-01
    “…Pooled sensitivity and specificity of SARS-CoV-2 Ag-IRRDTs did not demonstrate a significant superiority over SARS-CoV-2 rapid antigen tests which do not require a reader instrument, even in the case where surveillance and screening datasets were excluded from the analysis. …”
    Get full text
    Article
  18. 358

    SARS-CoV-2: Molecular Structure, Pathogenesis, Potential Therapeutic Targets, and Immune Response of the Infected Subject by R. Wumba, M. Mandina, Y. Nlandu, J. R. Makulo, A. Tshimpi, P. Mbala, A. Mbangama, P. Kabututu, J. M. Kayembe

    Published 2022-01-01
    “…Through a documentary review of literature, the authors describe virological and molecular aspects of SARS-CoV-2, the intimate mechanisms of cell infection, and potential therapeutic targets. …”
    Get full text
    Article
  19. 359
  20. 360